Cargando…

Neuroimaging features in inflammatory myelopathies: A review

Spinal cord involvement can be observed in the course of immune-mediated disorders. Although multiple sclerosis (MS) represents the leading cause of inflammatory myelopathy, an increasing number of alternative etiologies must be now considered in the diagnostic work-up of patients presenting with my...

Descripción completa

Detalles Bibliográficos
Autores principales: Cacciaguerra, Laura, Sechi, Elia, Rocca, Maria A., Filippi, Massimo, Pittock, Sean J., Flanagan, Eoin P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623025/
https://www.ncbi.nlm.nih.gov/pubmed/36330423
http://dx.doi.org/10.3389/fneur.2022.993645
_version_ 1784821900918128640
author Cacciaguerra, Laura
Sechi, Elia
Rocca, Maria A.
Filippi, Massimo
Pittock, Sean J.
Flanagan, Eoin P.
author_facet Cacciaguerra, Laura
Sechi, Elia
Rocca, Maria A.
Filippi, Massimo
Pittock, Sean J.
Flanagan, Eoin P.
author_sort Cacciaguerra, Laura
collection PubMed
description Spinal cord involvement can be observed in the course of immune-mediated disorders. Although multiple sclerosis (MS) represents the leading cause of inflammatory myelopathy, an increasing number of alternative etiologies must be now considered in the diagnostic work-up of patients presenting with myelitis. These include antibody-mediated disorders and cytotoxic T cell-mediated diseases targeting central nervous system (CNS) antigens, and systemic autoimmune conditions with secondary CNS involvement. Even though clinical features are helpful to orient the diagnostic suspicion (e.g., timing and severity of myelopathy symptoms), the differential diagnosis of inflammatory myelopathies is often challenging due to overlapping features. Moreover, noninflammatory etiologies can sometimes mimic an inflammatory process. In this setting, magnetic resonance imaging (MRI) is becoming a fundamental tool for the characterization of spinal cord damage, revealing a pictorial scenario which is wider than the clinical manifestations. The characterization of spinal cord lesions in terms of longitudinal extension, location on axial plane, involvement of the white matter and/or gray matter, and specific patterns of contrast enhancement, often allows a proper differentiation of these diseases. For instance, besides classical features, such as the presence of longitudinally extensive spinal cord lesions in patients with aquaporin-4-IgG positive neuromyelitis optica spectrum disorder (AQP4+NMOSD), novel radiological signs (e.g., H sign, trident sign) have been recently proposed and successfully applied for the differential diagnosis of inflammatory myelopathies. In this review article, we will discuss the radiological features of spinal cord involvement in autoimmune disorders such as MS, AQP4+NMOSD, myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and other recently characterized immune-mediated diseases. The identification of imaging pitfalls and mimics that can lead to misdiagnosis will also be examined. Since spinal cord damage is a major cause of irreversible clinical disability, the recognition of these radiological aspects will help clinicians achieve a correct and prompt diagnosis, treat early with disease-specific treatment and improve patient outcomes.
format Online
Article
Text
id pubmed-9623025
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96230252022-11-02 Neuroimaging features in inflammatory myelopathies: A review Cacciaguerra, Laura Sechi, Elia Rocca, Maria A. Filippi, Massimo Pittock, Sean J. Flanagan, Eoin P. Front Neurol Neurology Spinal cord involvement can be observed in the course of immune-mediated disorders. Although multiple sclerosis (MS) represents the leading cause of inflammatory myelopathy, an increasing number of alternative etiologies must be now considered in the diagnostic work-up of patients presenting with myelitis. These include antibody-mediated disorders and cytotoxic T cell-mediated diseases targeting central nervous system (CNS) antigens, and systemic autoimmune conditions with secondary CNS involvement. Even though clinical features are helpful to orient the diagnostic suspicion (e.g., timing and severity of myelopathy symptoms), the differential diagnosis of inflammatory myelopathies is often challenging due to overlapping features. Moreover, noninflammatory etiologies can sometimes mimic an inflammatory process. In this setting, magnetic resonance imaging (MRI) is becoming a fundamental tool for the characterization of spinal cord damage, revealing a pictorial scenario which is wider than the clinical manifestations. The characterization of spinal cord lesions in terms of longitudinal extension, location on axial plane, involvement of the white matter and/or gray matter, and specific patterns of contrast enhancement, often allows a proper differentiation of these diseases. For instance, besides classical features, such as the presence of longitudinally extensive spinal cord lesions in patients with aquaporin-4-IgG positive neuromyelitis optica spectrum disorder (AQP4+NMOSD), novel radiological signs (e.g., H sign, trident sign) have been recently proposed and successfully applied for the differential diagnosis of inflammatory myelopathies. In this review article, we will discuss the radiological features of spinal cord involvement in autoimmune disorders such as MS, AQP4+NMOSD, myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and other recently characterized immune-mediated diseases. The identification of imaging pitfalls and mimics that can lead to misdiagnosis will also be examined. Since spinal cord damage is a major cause of irreversible clinical disability, the recognition of these radiological aspects will help clinicians achieve a correct and prompt diagnosis, treat early with disease-specific treatment and improve patient outcomes. Frontiers Media S.A. 2022-10-18 /pmc/articles/PMC9623025/ /pubmed/36330423 http://dx.doi.org/10.3389/fneur.2022.993645 Text en Copyright © 2022 Cacciaguerra, Sechi, Rocca, Filippi, Pittock and Flanagan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Cacciaguerra, Laura
Sechi, Elia
Rocca, Maria A.
Filippi, Massimo
Pittock, Sean J.
Flanagan, Eoin P.
Neuroimaging features in inflammatory myelopathies: A review
title Neuroimaging features in inflammatory myelopathies: A review
title_full Neuroimaging features in inflammatory myelopathies: A review
title_fullStr Neuroimaging features in inflammatory myelopathies: A review
title_full_unstemmed Neuroimaging features in inflammatory myelopathies: A review
title_short Neuroimaging features in inflammatory myelopathies: A review
title_sort neuroimaging features in inflammatory myelopathies: a review
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623025/
https://www.ncbi.nlm.nih.gov/pubmed/36330423
http://dx.doi.org/10.3389/fneur.2022.993645
work_keys_str_mv AT cacciaguerralaura neuroimagingfeaturesininflammatorymyelopathiesareview
AT sechielia neuroimagingfeaturesininflammatorymyelopathiesareview
AT roccamariaa neuroimagingfeaturesininflammatorymyelopathiesareview
AT filippimassimo neuroimagingfeaturesininflammatorymyelopathiesareview
AT pittockseanj neuroimagingfeaturesininflammatorymyelopathiesareview
AT flanaganeoinp neuroimagingfeaturesininflammatorymyelopathiesareview